Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Pediatr Infect Dis J ; 40(2): e85-e86, 2021 02 01.
Artículo en Inglés | MEDLINE | ID: covidwho-915932

RESUMEN

We report an infant with COVID-19 who presented with bloody stools, lethargy and imaging findings significant for pneumatosis intestinalis. The infant was treated with conservative therapy, including resuscitation, bowel rest and intravenous antibiotics, successfully avoiding surgical intervention.


Asunto(s)
COVID-19/complicaciones , COVID-19/diagnóstico por imagen , Enterocolitis Necrotizante/complicaciones , Enterocolitis Necrotizante/diagnóstico por imagen , COVID-19/fisiopatología , COVID-19/terapia , Colon/diagnóstico por imagen , Enterocolitis Necrotizante/fisiopatología , Enterocolitis Necrotizante/terapia , Heces , Humanos , Lactante , Unidades de Cuidados Intensivos , Masculino , SARS-CoV-2/aislamiento & purificación
2.
Medicina (Kaunas) ; 56(9)2020 Aug 27.
Artículo en Inglés | MEDLINE | ID: covidwho-738923

RESUMEN

The positive impact of probiotic strains on human health has become more evident than ever before. Often delivered through food, dietary products, supplements, and drugs, different legislations for safety and efficacy issues have been prepared. Furthermore, regulatory agencies have addressed various approaches toward these products, whether they authorize claims mentioning a disease's diagnosis, prevention, or treatment. Due to the diversity of bacteria and yeast strains, strict approaches have been designed to assess for side effects and post-market surveillance. One of the most essential delivery systems of probiotics is within food, due to the great beneficial health effects of this system compared to pharmaceutical products and also due to the increasing importance of food and nutrition. Modern lifestyle or various diseases lead to an imbalance of the intestinal flora. Nonetheless, as the amount of probiotic use needs accurate calculations, different factors should also be taken into consideration. One of the novelties of this review is the presentation of the beneficial effects of the administration of probiotics as a potential adjuvant therapy in COVID-19. Thus, this paper provides an integrative overview of different aspects of probiotics, from human health care applications to safety, quality, and control.


Asunto(s)
Infecciones por Coronavirus/prevención & control , Suplementos Dietéticos/normas , Enfermedades Gastrointestinales/terapia , Hepatopatías/terapia , Pandemias/prevención & control , Neumonía Viral/prevención & control , Probióticos/uso terapéutico , Betacoronavirus , COVID-19 , Enfermedad Celíaca/terapia , Infecciones por Clostridium/terapia , Estreñimiento/terapia , Infecciones por Coronavirus/tratamiento farmacológico , Infecciones por Coronavirus/terapia , Trastorno Depresivo/terapia , Enfermedades Diverticulares/terapia , Disentería/terapia , Enterocolitis Necrotizante/terapia , Alimentos Fermentados , Hipersensibilidad a los Alimentos/terapia , Infecciones por Helicobacter/terapia , Encefalopatía Hepática/terapia , Humanos , Enfermedades Inflamatorias del Intestino/terapia , Enfermedad del Hígado Graso no Alcohólico/terapia , Neumonía Viral/terapia , Probióticos/efectos adversos , Probióticos/normas , Control de Calidad , SARS-CoV-2 , Tratamiento Farmacológico de COVID-19
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA